At the CED Life Sciences Conference this week, Sanofi CEO Chris Viehbacher said that researchers who work for big pharma tend to be the least innovative, reports Pharmalot's Ed Silverman. The best scientists, Viehbacher said, work for small biotechs — that's why Sanofi is reducing its internal research capacity and partnering with outside companies, biotechs, and universities to get R&D done.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.